NYSE · LLY
Eli Lilly and Company
$1,417.54+$43.84 (+3.19%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.22% below the high.
Loading market information…
OTC · APYI · USD
Stock price
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Aspyra Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Aspyra Inc. specializes in healthcare solutions, delivering essential products and services to both the laboratory and medical imaging industries. The company provides meticulously crafted workflow systems, which encompass software, connectivity tools, physical hardware, and expert support services. These solutions are adopted by a diverse range of healthcare organizations, such as specialized and reference laboratories, medical clinics, hospitals, diagnostic imaging centers, and orthopedic practices. Established in 1978, the enterprise initially operated as Creative Computer Applications Inc., officially adopting the Aspyra Inc. name in November 2005. Its corporate headquarters are located in Jacksonville, Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:19 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1,417.54+$43.84 (+3.19%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.22% below the high.
$76.57+$0.15 (+0.2%)
GE HealthCare Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.7% below the high.
$72.22-$5.62 (-7.22%)
Tempus AI, Inc.’s quoted price sits in the upper half of its reported 52-week range, 20.23% below the high.
$12.44-$0.09 (-0.72%)
Phreesia, Inc.’s quoted price sits in the lower half of its reported 52-week range, 47.69% below the high.
$1.78-$0.14 (-7.29%)
VSee Health, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.15% below the high.
$0.10+$0.04 (+66.67%)
FOXO Technologies Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.61% below the high.
$0.00$0.00 (0.0%)
Advanced BioMedical Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Amexdrug Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
